Question 1

What are the potential benefits and risks of Fractionated Laser Resurfacing for my skin condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia clinical trial (NCT03906253). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia clinical trial (NCT03906253). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the follow-up process look like after the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia clinical trial (NCT03906253). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia clinical trial (NCT03906253). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in this study, and what will the visits involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia clinical trial (NCT03906253). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience any complications during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia clinical trial (NCT03906253). Contact the study team or your healthcare provider for specific answers.

What this study is about